Markets finish week down after bouncing on Bannon's exit >>> READ MORE

Trade of the Day: 3 Small-Cap Stocks Under $10 Set to Spike

Three small-cap gems could deliver big-time gains in the short term

      View All  

The chart for micro-cap Galena Biopharma (GALE), an oncological treatment firm, showed a bullish Continuation Wedge at Monday’s closing price of $3.22. The bullish pattern indicates that GALE could move 70% or more to a target of $5.50 to $6.00 in the next 24 trading days. GALE is down in Tuesday’s trading, but that could simply offer an even better entry point for traders.


Chart courtesy of Recognia

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC